Moritz Drefs,Markus B. Schoenberg,Nikolaus Börner,Dionysios Koliogiannis,Dominik Koch,Malte Schirren,Joachim Andrassy,Alexandr V. Bazhin,Jens Werner,Markus Guba
Hepatocellular Carcinoma (HCC) still is one of the most detrimental malignant diseases in the world. As two curative surgical therapies exist, the discussion whether to opt for liver resection (LR) or transplantation (LT) is ongoing, especially as novel techniques to improve outcome have emerged for both. The aim of the study was to investigate how the utilization and outcome of the respective modalities changed through time.